MedPath

Effect of Intraoperative Magnesium on Remifentanil-induced Postoperative Hyperalgesia After Thyroidectomy

Phase 4
Completed
Conditions
Hyperalgesia
Interventions
Drug: remifentanil, MgSO4
Registration Number
NCT01025245
Lead Sponsor
Yonsei University
Brief Summary

The purpose of this study is to study the effect of intraoperative magnesium on remifentanil-induced postoperative hyperalgesia after thyroidectomy

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • Patients undergoing thyroidectomy,
  • Age 20-65,
  • American Society of Anesthesiologists physical status classification I or II.
Exclusion Criteria
  • History of chronic pain, Regular use of analgesic, antiepileptic or antidepressive drugs,
  • History of drug & alcohol abuse,
  • Psychiatric disorder,
  • Use of opioids within 24hrs,
  • Renal disease with decreased GFR,
  • Neuromuscular disease, Severe cardiac disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
remifentanil, MgSO4remifentanil, MgSO4Experimental 1 : Intraoperative remifentanil infusion at 0.2 ㎍/㎏/min and MgSO4 30 mg/kg IV at the induction followed by intraoperative infusion at 10 mg/kg/hr Drug : remifentanil, MgSO4 Experimental 2 : Intraoperative remifentanil infusion at 0.2 ㎍/㎏/min and normal saline Drug : remifentanil Active comparator : Intraoperative remifentanil infusion at 0.05 ㎍/㎏/min and normal saline Drug : remifentanil
Primary Outcome Measures
NameTimeMethod
Tactile pain thresholds adjacent to the surgical wound assessed by von Frey hair before the induction and at postoperative 24 & 48 hrspostoperative 48 hrs
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath